Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
FRANKFURT:6NQ
Holding DE:6NQ?
Track your performance easily
6NQ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.63 - €1.30
Previous Close€0.85
Volume0.00
Average Volume (3M)N/A
Market Cap
€71.13M
Enterprise Value€68.45M
Total Cash (Recent Filing)zł26.77M
Total Debt (Recent Filing)zł15.15M
Price to Earnings (P/E)78.0
Beta0.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)14.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
6NQ FAQ
What was Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s price range in the past 12 months?
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. lowest stock price was €0.63 and its highest was €1.30 in the past 12 months.
What is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s market cap?
Currently, no data Available
When is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s earnings last quarter?
Currently, no data Available
Is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. overvalued?
According to Wall Street analysts Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s price is currently Overvalued.
Does Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. pay dividends?
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. does not currently pay dividends.
What is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s EPS estimate?
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. have?
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. has 70,770,580 shares outstanding.
What happened to Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.?
Currently, no hedge funds are holding shares in DE:6NQ
---
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.96%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
55.54%
Trailing 12-Months
Company Description
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
Biomed-Lublin Wytwornia Surowic i Szczepionek SA is a pharmaceutical company. The company is engaged in the developing products and therapeutic indications and conducting clinical trials in cooperation with scientific and medical centers. Its products include Prescription drugs, Medical products and Report an adverse reaction.
---
Technical Analysis
---